Status:
COMPLETED
Spinal Analgesia for Colonic Resection Using an Enhanced Recovery After Surgery (ERAS) Program
Lead Sponsor:
McGill University Health Centre/Research Institute of the McGill University Health Centre
Conditions:
Colon Cancer
Inflammatory Bowel Diseases
Eligibility:
All Genders
18-90 years
Phase:
PHASE1
PHASE2
Brief Summary
This is a blinded randomized controlled trial in patients undergoing laparoscopic colon surgery. The aim of this study is to assess whether spinal analgesia with a mixture of bupivacaine and morphine ...
Detailed Description
This is a blinded randomized controlled trial in patients undergoing laparoscopic colon surgery. The aim of this study is to assess whether spinal analgesia with a mixture of bupivacaine and morphine ...
Eligibility Criteria
Inclusion
- patients scheduled to undergo laparoscopic colonic resection
Exclusion
- patients who have trouble to understand, read or communicate either in French or in English
- dementia
- patients suffering from severe physical disability (arthritis, neuromuscular dysfunction, stroke, paraplegia) or inability to walk or conduct daily activity
- patients suffering from severe cardiac or respiratory disease (status ASA IV)
- patients suffering from metastatic carcinoma
- patients who have a history of chemoradiation within the six months preceding surgery
- morbid obesity
- contraindication to spinal analgesia
Key Trial Info
Start Date :
October 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2011
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01477190
Start Date
October 1 2010
End Date
October 1 2011
Last Update
November 28 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Montreal General Hospital
Montreal, Quebec, Canada, H3G1A4